The Big Treatment Questions
When do experts recommend starting treatment and which antiretrovirals should you take first?
When should you change your treatments and which drugs should you switch to?
What is drug resistance?
Can you take a break from treatment?
& more.
FDA Approves First Drug to Treat Diarrhea in People With HIV
The U.S. Food and Drug Administration (FDA) has approved Fulyzaq (crofelemer), the first drug to relieve symptoms of diarrhea that is a side effect of HIV antiretrovirals (ARVs). Intended for use among people with HIV who are taking ARVs and whose diarrhea is not caused by a virus, bacteria or parasite, the drug treats watery diarrhea that is a consequence of electrolyte secretion and water in the gastrointestinal tract.
Read more… http://www.poz.com/articles/fulyzaq_crofelemer_salix_761_23339.shtml
Stribild, the once-daily four-in-one fixed-dose combination (FDC) tablet formerly known as the “Quad,” has been approved for people living with HIV initiating antiretroviral (ARV) therapy for the first time, according to announcements by Gilead Sciences and the U.S. Food and Drug Administration released on Monday, August 27.
From the Newsfeed
Drug dealers in the Washington Heights neighborhood of New York City, which is heavily populated with immigrants and descendants from the Dominican Republic, are illegally buying prescription drugs, including HIV medications, and selling the meds to their country of origin. Click here for more.
FDA Warns Companies Selling Fake Remedies for HIV
The U.S. Food and Drug Administration (FDA) is sending dozens of warning letters to companies selling bogus pills and supplements that claim to cure or prevent sexually transmitted infections such as HIV, herpes and genital warts.
A drug widely used to control HIV in infected individuals may have a beneficial side effect. It appears that this drug can also attack Human Papilloma Virus (HPV), the primary cause of cervical cancer.
It’s an interesting finding, because the drug appears to work in an entirely different manner on HPV than it does on HIV. The two viruses are extremely different in their biology.
This is indeed an interesting study. Click here to read our expanded coverage.
This animation explains why people in developing countries can’t get the HIV medicines they need to survive and how setting up a ‘patent pool’ could change that. MSF calls on researchers and pharmaceutical companies: put your patents in the pool!
Interesting ad. This is the first ad I’ve seen that covers the topic of patents and patent pools. It can get complicated. Check out some of our coverage here.
An internal investigation by the Global Fund to Fight AIDS, Tuberculosis and Malaria has determined millions of dollars of its donated malaria drugs have been stolen in recent years. Click here for more.
About POZ
